Efficacy, safety, and immunogenicity of UB-851 versus ® in patients with renal anemia receiving hemodialysis: A randomized, double-masked, phase III trial.
- DOI
- 10.1097/jcma.0000000000001327
- Published
- 2026 Jan 1
- Container
- Journal of the Chinese Medical Association : JCMA
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/jcma.0000000000001327,
title = {Efficacy, safety, and immunogenicity of UB-851 versus ® in patients with renal anemia receiving hemodialysis: A randomized, double-masked, phase III trial.},
author = {Wu CH and Shiao CC and Wang HY and Tian YC and Chiu YW and Huang WH and Tsai SH and Fang HC and Lee CC and Hsu BG and Chang HR and Lin CY and Chan CH and Wang WJ and Huang KC and Chen SC and Wang CL and Huang CY and Tarng DC},
year = {2026},
journal = {Journal of the Chinese Medical Association : JCMA},
doi = {10.1097/jcma.0000000000001327},
url = {https://doi.org/10.1097/jcma.0000000000001327}
}RIS
TY - JOUR TI - Efficacy, safety, and immunogenicity of UB-851 versus ® in patients with renal anemia receiving hemodialysis: A randomized, double-masked, phase III trial. AU - Wu CH AU - Shiao CC AU - Wang HY AU - Tian YC AU - Chiu YW AU - Huang WH AU - Tsai SH AU - Fang HC AU - Lee CC AU - Hsu BG AU - Chang HR AU - Lin CY AU - Chan CH AU - Wang WJ AU - Huang KC AU - Chen SC AU - Wang CL AU - Huang CY AU - Tarng DC PY - 2026 JO - Journal of the Chinese Medical Association : JCMA DO - 10.1097/jcma.0000000000001327 UR - https://doi.org/10.1097/jcma.0000000000001327 ER -
APA
CH, W., CC, S., HY, W., YC, T., YW, C., WH, H., SH, T., HC, F., CC, L., BG, H., HR, C., CY, L., CH, C., WJ, W., KC, H., SC, C., CL, W., CY, H., & DC, T. (2026). Efficacy, safety, and immunogenicity of UB-851 versus ® in patients with renal anemia receiving hemodialysis: A randomized, double-masked, phase III trial.. Journal of the Chinese Medical Association : JCMA. https://doi.org/10.1097/jcma.0000000000001327
Source records
- pubmed · retrieved 2026-09-26T13:37:43.680Z
- europe-pmc · retrieved 2026-09-26T13:37:43.678Z